Effects of Kinesio Taping in Patients With Somatosensory Tinnitus
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03782220 |
Recruitment Status :
Completed
First Posted : December 20, 2018
Last Update Posted : December 20, 2018
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Tinnitus, Subjective | Other: Kinesio tape Other: Shame tape | Not Applicable |
The study was designed as a prospective, randomized controlled and double blind trial.
Patients complaining of tinnitus were firstly subjected to otologic and audiologic evaluation by an otolaryngologist. Tinnitus characteristics, such as severity (Tinnitus handicap Index, tinnitus Visual Analog Scale- tinnitus VAS) , type (pulsatile/non-pulsatile), localization (unilateral/ bilateral) and the frequency (number of days with symptoms) were recorded. Patients were excluded if they had objective tinnitus, subjective tinnitus with hearing loss or Meniere's disease, vertigo, middle ear pathologies, intracranial pathologies, whiplash injury, previous cervical spinal surgery, pregnancy, infection, malignancy and if they received cervical physical rehabilitation program in the past 3 months.
Patients who diagnosed with somatosensory tinnitus and concomitant neck complaints (cervical-VAS score >2) at least 6 weeks were referred to physical medicine and rehabilitation outpatient clinic. Before the treatment, participants' demographics data including age, gender, Body-Mass Index (BMI) and cervical pain VAS score were recorded and physical examinations (cervical joint range of motion (cervical-ROM), cervical manual muscle testing (cervical-MMT) and myofascial trigger points for sternocleidomastoid, upper trapezium and levator scapulae muscles) were performed by one investigator.
Banding application performed for both groups once a week for four weeks. Tinnitus handicap index score, tinnitus VAS, ROM of the cervical joint, cervical MMT, cervical pain VAS, Neck Disability index score and myofascial trigger points of sternocleidomastoid, upper trapezium, levator scapula was evaluated in all subjects by the same investigator.
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 37 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Double (Participant, Investigator) |
Primary Purpose: | Treatment |
Official Title: | Effects of Kinesio Taping in Patients With Somatosensory Tinnitus: A Randomized Controlled Trial |
Actual Study Start Date : | September 20, 2017 |
Actual Primary Completion Date : | April 18, 2018 |
Actual Study Completion Date : | September 7, 2018 |
Arm | Intervention/treatment |
---|---|
Experimental: Kinesio taping group
Kinesio taping group
|
Other: Kinesio tape
The Kinesio taping ( Kinesio Tex Gold, 2in x103.3 ft) was applied to sternocleidomastoid, upper trapezium and levator scapulae muscles by the muscle inhibition technique ( from insertion to origin of a muscle) for experimental group. |
Placebo Comparator: Shame taping group
Shame taping group
|
Other: Shame tape
For the Shame taping group, a placebo taping method considered to be ineffective ( not from insertion to origin of muscles) with the same material without tension and with the neck in neutral position was used. |
- Tinnitus handicap Index (THI) [ Time Frame: 4 weeks ]The questionnaire comprises 25 items with a functional subscale (11 items), emotional subscale (9 items), and catastrophic subscale (5 items). Each question is rated as 0 (none), 2 (sometimes), or 4 (always). Total score range from 0 to 100, with higher scores indicating higher levels of perceived tinnitus handicap.
- Tinnitus severity (tinnitus-VAS) [ Time Frame: 4 weeks ]The loudness of tinnitus was graded with a10 cm of visual analog scale (VAS, 0-10 cm; 0 means no tinnitus, 10 means extremely loud tinnitus)
- Cervical pain (cervical-VAS) [ Time Frame: 4 weeks ]Pain intensity was measured with VAS which is used to measure musculoskeletal pain with very good reliability and validity (VAS, 0-10 cm; 0 means no pain, 10 means severe pain).
- Neck Disability index score (NDI) [ Time Frame: 4 weeks ]The NDI is designed to assess self - reported neck functional status. The questionnaire comprises 10 items related to pain, activities of daily living, lifting, reading, headaches, concentration, work status, driving, sleeping and recreation, each rated on a 6-point Likert scale with a final score range of 0 (no disability) to 50 (major disability). Higher scores represent greater disability

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 65 Years (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Subject has somatosensory tinnitus
- Subject has concomitant neck complaints (cervical-VAS score >2) at least 6 weeks
- Subject were referred to physical medicine and rehabilitation outpatient clinic
Exclusion Criteria:
- History of objective tinnitus
- History of subjective tinnitus with hearing loss
- History of Meniere's disease
- History of vertigo
- Hiistory of middle ear pathologies
- History of intracranial pathologies
- History of whiplash injury
- History of previous cervical spinal surgery
- History of infection or malignancy
- Pregnancy
- History of having received cervical physical rehabilitation program in the past 3 months

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03782220
Turkey | |
Tuğba Atan | |
Çorum, Turkey, 19100 |
Responsible Party: | Tuğba Atan, Assoc. Prof., Hitit University |
ClinicalTrials.gov Identifier: | NCT03782220 |
Other Study ID Numbers: |
2018-12 |
First Posted: | December 20, 2018 Key Record Dates |
Last Update Posted: | December 20, 2018 |
Last Verified: | December 2018 |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
somatosensory tinnitus neck pain kinesio taping |
Tinnitus Hearing Disorders Ear Diseases Otorhinolaryngologic Diseases |
Sensation Disorders Neurologic Manifestations Nervous System Diseases |